Spironolactone Noninferior in Duchenne Muscular Dystrophy

08:00 EDT 28 Oct 2019 |

MONDAY, Oct. 28, 2019 -- In a head-to-head study of mineralocorticoid receptor antagonists, spironolactone was found to be noninferior to eplerenone for slowing the progression of heart damage in boys with Duchenne muscular dystrophy (DMD),...

Original Article: Spironolactone Noninferior in Duchenne Muscular Dystrophy


More From BioPortfolio on "Spironolactone Noninferior in Duchenne Muscular Dystrophy"

Quick Search

Relevant Topics

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Muscular Dystrophy
Muscular dystrophy is a group of degenerative inherited disorders causing muscle weakness and loss of muscle tissue. The different types are Becker muscular dystrophy, Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, Facioscapulohumeral mu...